Tirzepatide 90mg*10vials

描述

Core Features
$\ge 99.0\%$ Ultra-High Purity & High-Capacity Consistency: Produced using industry-leading automated high-throughput solid-phase peptide synthesis (SPPS) technology. Given Tirzepatide’s complex 39-amino acid chain structure and $\text{C}_{20}$ fatty diacid side chain, achieving high purity at a 90mg scale presents a significant challenge. We employ precise industrial-scale reversed-phase preparative HPLC (RP-HPLC) to rigorously eliminate truncated sequences and non-specifically modified by-products. Each 90mg vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for large-scale in vitro and long-term in vivo studies.
Synergistic Dual-Target Mechanism: Tirzepatide exerts profound metabolic regulatory effects through an innovative dual-receptor agonism mechanism: GIP receptor pathway (GIPR)—synergistically regulating lipid storage homeostasis and enhancing sensitivity to endogenous insulin; GLP-1 receptor pathway (GLP-1R)—optimizing glucose-dependent insulin secretion and improving satiety and overall energy metabolic efficiency. The 90mg format supports standardized, multi-season screening in large-scale core facilities, ensuring consistent receptor-agonizing potency across all experimental groups. Advanced Cryo-Lyophilization Lock: Moisture sublimation of the high-concentration (90mg) peptide powder occurs at $-80^\circ\text{C}$ under near-absolute vacuum, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process ensures that the peptide’s spatial secondary structure remains “locked” in a stable state during prolonged storage, significantly enhancing biological activity stability upon reconstitution.

🛠️ Technical Specifications & Parameters
Product Specification: 90 mg / Vacuum-Sealed Glass Vial
Molecular Formula: $\text{C}_{225}\text{H}_{348}\text{N}_{48}\text{O}_{68}$
Appearance: White to off-white sterile lyophilized powder / intact solid cake
Validation: Supplied with original manufacturer HPLC purity chromatograms and MS molecular weight verification reports.

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be immediately stored in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Maintain conditions protected from light and moisture, ensuring a high-vacuum seal throughout. Researchers are strongly advised to aliquot the product into single-experiment doses and freeze them to establish a standardized master stock; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: The 90mg Tirzepatide is shipped via express service using high-density, reinforced five-layer insulated foam boxes combined with high-capacity phase-change gel packs. This ensures the peptide’s higher-order spatial conformation remains “locked” in a stable, frozen state while traversing diverse global climate zones.

📝 Research Limitations & Compliance
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Tirzepatide 90mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted solely to academic research conducted in university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., experiments on cell receptor binding affinity, high-throughput drug screening, and long-term metabolic cohort monitoring in large animals). Any unauthorized use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent, performance-enhancing drug, or stimulant—is strictly prohibited. This platform enforces rigorous multi-level verification of the “End-Use Statement”; any order suspected of involving misuse will be unconditionally cancelled and reported to the relevant compliance authorities.